Literature DB >> 20842682

Some essential clarifications: IQWiG comments on two critiques of the efficiency frontier approach.

Charalabos-Markos Dintsios1, Andreas Gerber.   

Abstract

Mesh：

Year:  2010        PMID： 20842682     DOI： 10.1002/hec.1657

Source DB:  PubMed          Journal:  Health Econ        ISSN： 1057-9230            Impact factor:   3.046


× No keyword cloud information.
  4 in total

Review 1.  A systematic review of moral reasons on orphan drug reimbursement.

Authors:  Bettina M Zimmermann; Johanna Eichinger; Matthias R Baumgartner
Journal:  Orphanet J Rare Dis       Date:  2021-06-30       Impact factor: 4.123

2.  Adapting Pharmacoeconomics to Shape Efficient Health Systems en Route to UHC - Lessons from Two Continents.

Authors:  Jacqui Miot; Michael Thiede
Journal:  Front Pharmacol       Date:  2017-10-10       Impact factor: 5.810

3.  Communicating the parameter uncertainty in the IQWiG efficiency frontier to decision-makers.

Authors:  Björn Stollenwerk; Stefan K Lhachimi; Andrew Briggs; Elisabeth Fenwick; Jaime J Caro; Uwe Siebert; Marion Danner; Andreas Gerber-Grote
Journal:  Health Econ       Date:  2014-03-04       Impact factor: 3.046

4.  Early decision-analytic modeling - a case study on vascular closure devices.

Authors:  Alina Brandes; Moritz F Sinner; Stefan Kääb; Wolf H Rogowski
Journal:  BMC Health Serv Res       Date:  2015-10-27       Impact factor: 2.655
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.